Creighton University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Omaha NE United States (1878)

Organization Overview

First Clinical Trial
1995
NCT00000426
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Creighton Cardiac Center | Creighton Cardiology | Creighton University | Creighton University Department of Psychiatry | Creighton University Division of Allergy & Immunology | Creighton University Medical Center | Creighton University, Omaha (NE) | Creighton University Osteoporosis Research Center | Creighton University School of Medicine / CHI Health | Dean Emeritus, Creighton University Health Sciences Center | John Cote

Active Ingredients

Drugs in Phase 4 Trials (46)

acetylsalicylic acid (aspirin) (2 trials)

aminocaproic acid (amicar) (1 trial)

amlodipine (norvasc) (1 trial)

aripiprazole (abilify) (1 trial)

atenolol (tenormin) (1 trial)

atorvastatin (lipitor) (1 trial)

bupivacaine (Exparel) (1 trial)

calcitriol (rocaltrol) (1 trial)

calcium carbonate (4 trials)

carbamazepine (tegretol) (1 trial)

carvedilol (coreg) (1 trial)

chlorthalidone (Hygroton) (2 trials)

clonidine (catapres) (1 trial)

clopidogrel (plavix) (2 trials)

doxazosin (cardura) (1 trial)

epinephrine (levophed) (1 trial)

ergocalciferol (drisdol) (2 trials)

fluoxetine (prozac) (1 trial)

grapefruit juice (1 trial)

hydralazine (apresoline) (1 trial)

hydrochlorothiazide (esidrix) (3 trials)

levobupivacaine (chirocaine) (1 trial)

lidocaine (xylocaine) (1 trial)

lisinopril (zestril) (1 trial)

lithium (lithonate) (1 trial)

methylprednisolone (medrol) (1 trial)

metoprolol (lopressor) (3 trials)

minocycline (minocin) (1 trial)

mometasone (elocon) (1 trial)

morphine (1 trial)

nicotine (nicorette) (1 trial)

nifedipine (procardia) (1 trial)

omalizumab (xolair) (5 trials)

paricalcitol (zemplar) (1 trial)

quetiapine (seroquel) (2 trials)

risperidone (risperdal) (2 trials)

topiramate (topamax) (1 trial)

tranexamic acid (cyklokapron) (1 trial)

ubiquinone (1 trial)

valproic acid (depakene) (1 trial)

valsartan (diovan) (1 trial)

vancomycin (Vancocin) (1 trial)

vitamin d3 (16 trials)

warfarin (coumadin) (1 trial)

wheat (1 trial)

ziprasidone (geodon) (1 trial)

Drugs in Phase 3 Trials (6)

alendronic acid (fosamax) (1 trial)

calcium (4 trials)

estrogen (1 trial)

lactobacillus rhamnosus (1 trial)

progestin (1 trial)

risedronate (actonel) (1 trial)

Drugs in Phase 2 Trials (7)

calcium phosphate (1 trial)

cyt003-qbg10 (1 trial)

denosumab (prolia) (1 trial)

short ragweed pollen allergen (1 trial)

sitagliptin (januvia) (1 trial)

sodium chloride (1 trial)

teriparatide (1 trial)

Drugs in Phase 1 Trials (1)

testosterone (delatestryl) (1 trial)

Drugs in Other Trials (15)

calcium citrate (1 trial)

egg (1 trial)

eplerenone (inspra) (1 trial)

ezetimibe (zetia) (1 trial)

fluticasone (cutivate) (2 trials)

furosemide (lasix) (1 trial)

glucose (1 trial)

Hesperedin (1 trial)

lactose (1 trial)

montelukast (singulair) (1 trial)

naringen (1 trial)

nebivolol (bystolic) (1 trial)

salmeterol (serevent) (1 trial)

soybean (1 trial)

synthenate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcoholism (Phase 4)

Anxiety Disorders (Phase 4)

Asthma (Phase 4)

Atrial Fibrillation (Phase 4)

Behavior, Addictive (Phase 4)

Bipolar Disorder (Phase 4)

Bone Diseases, Metabolic (Phase 3)

Breast Neoplasms (Phase 1)

Compulsive Personality Disorder (Phase 4)

Constipation (Phase 4)

Coronary Artery Disease (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Disease (Phase 4)

Dyspareunia (Phase 1)

Embolism (Phase 4)

Heart Diseases (Phase 4)

Hyperparathyroidism (Phase 4)

Hyperparathyroidism, Secondary (Phase 4)

Hypersensitivity (Phase 2)

Hypertension (Phase 4)

Inflammation (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Lung Diseases (Phase 4)

Malnutrition (Phase 3)

Myalgia (Phase 4)

Obsessive-Compulsive Disorder (Phase 4)

Osteoarthritis (Phase 4)

Osteoporosis (Phase 3)

Pain, Postoperative (Phase 4)

Panic Disorder (Phase 4)

Pneumonia (Phase 3)

Pneumonia, Ventilator-Associated (Phase 3)

Premature Birth (Phase 1)

Psychotic Disorders (Phase 4)

Pulmonary Embolism (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Respiratory Hypersensitivity (Phase 4)

Rhinitis (Phase 2)

Rhinitis, Allergic, Seasonal (Phase 2)

Schizophrenia (Phase 4)

Stress Disorders, Post-Traumatic (Phase 4)

Stress Disorders, Traumatic (Phase 4)

Substance-Related Disorders (Phase 4)

Thrombosis (Phase 4)

Venous Thrombosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 69
  • # of Trial APIs: 75